Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9308973 | 1.00 | GAA (0.41) | GAANPSR1POLBCYP3A4CYP1A2 | |
| SCHEMBL8246813 | 1.00 | GAA (0.41) | GAANPSR1POLBCYP3A4CYP1A2 | |
| SCHEMBL13198671 | 1.00 | GAA (0.41) | GAANPSR1POLBCYP3A4CYP1A2 | |
| SCHEMBL418070 | 1.00 | GAA (0.41) | GAANPSR1POLBCYP3A4CYP1A2 | |
| SCHEMBL3739039 | 0.91 | ALDH1A1 (0.49) | GAANPSR1POLBTSHRHSD17B10 | |
| SCHEMBL5823247 | 0.91 | ALDH1A1 (0.49) | GAANPSR1POLBTSHRHSD17B10 | |
| SCHEMBL417370 | 0.91 | ALDH1A1 (0.49) | GAANPSR1POLBTSHRHSD17B10 | |
| SCHEMBL5768836 | 0.91 | ALDH1A1 (0.49) | GAANPSR1POLBTSHRHSD17B10 | |
| SCHEMBL418463 | 0.91 | ALDH1A1 (0.49) | GAANPSR1POLBTSHRHSD17B10 | |
| SCHEMBL19730192 | 0.91 | ALDH1A1 (0.49) | GAANPSR1POLBTSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115710538-A | Self-emulsifying cleaning material and preparation method and application thereof | 国网上海市电力公司 | 2023-02-24 | — | — | CN | claimed |
| CN-119331130-B | Solid catalyst component for olefin polymerization, olefin polymerization catalyst and application thereof | 中国石油天然气股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-119331130-A | Solid catalyst component for olefin polymerization, olefin polymerization catalyst and application thereof | 中国石油天然气股份有限公司 | 2025-01-21 | — | — | CN | disclosed |
| CN-118063652-A | Process for producing propylene copolymers using catalyst systems with improved copolymerization activity | 韩华道达尔能源有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-115710538-B | Self-emulsifying cleaning material and preparation method and application thereof | 国网上海市电力公司 | 2024-01-19 | — | — | CN | disclosed |
| CN-115710538-A | Self-emulsifying cleaning material and preparation method and application thereof | 国网上海市电力公司 | 2023-02-24 | — | — | CN | disclosed |
| CN-111171195-B | Propylene polymerization solid catalyst for reducing VOC and method for producing polypropylene using the same | 韩华道达尔能源有限公司 | 2022-12-27 | — | — | CN | disclosed |
| EP-3054947-B1 | CATHEPSIN CYSTEINE PROTEASE INHIBITORS | MERCK SHARP & DOHME (US) | 2021-11-17 | — | — | EP | disclosed |
| EP-3104705-B1 | CATHEPSIN CYSTEINE PROTEASE INHIBITORS | MERCK SHARP & DOHME (US) | 2021-11-03 | — | — | EP | disclosed |
| CN-111171195-A | Propylene polymerization solid catalyst for reducing VOC and method for producing polypropylene using the same | 韩华道达尔有限公司 | 2020-05-19 | — | — | CN | disclosed |
| US-20080200406-A1 | Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines | GLYCOMIMETICS, INC. (US) | 2008-08-21 | — | — | US | disclosed |
| US-7368564-B2 | Bridged macrocyclic module compositions | COVALENT PARTNERS, LLC (US) | 2008-05-06 | — | — | US | disclosed |
| US-20070154882-A1 | Beta-polypeptides that inhibit cytomegalovirus infection | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-07-05 | — | — | US | disclosed |
| US-20070154882-A1 | Beta-polypeptides that inhibit cytomegalovirus infection | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-07-05 | — | — | US | disclosed |
| US-20070123709-A1 | Beta-amino acids | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-05-31 | — | — | US | disclosed |
| US-20070123709-A1 | Beta-amino acids | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-05-31 | — | — | US | disclosed |
| US-6958384-B2 | Polypeptides containing γ-amino acids | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2005-10-25 | — | — | US | disclosed |
| US-20040116654-A1 | Heterogeneous foldamers containing alpha, beta, and/or gamma-amino acids | NATIONAL SCIENCE FOUNDATION | 2004-06-17 | — | — | US | disclosed |
| US-20030211999-A1 | Polypeptides containing gamma-amino acids | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2003-11-13 | — | — | US | disclosed |
| US-5274119-A | Vicinal diols | THE DOW CHEMICAL COMPANY (US) | 1993-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070123709-A1 | Beta-amino acids | BCAT1, MARCKS, YWHAZ | GAA 3215/4885NPSR1 1818/4885POLB 1051/4885 |
| US-20030211999-A1 | Polypeptides containing gamma-amino acids | PEPD, DNPEP, ANPEP | GAA 790/4885NPSR1 515/4885POLB 982/4885 |
| US-20080200406-A1 | Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines | FUT6, ENGASE, FUT5 | GAA 131/4885NPSR1 1716/4885POLB 3648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.